Patrick Kennedy profits from opioid-addiction firms

Patrick Kennedy, the former Democratic representative and scion of the liberal political dynasty, has emerged as the unlikely go-to player for companies seeking to benefit from the Trump administration's multibillion-dollar response to the opioid crisis, reaping well over $1 million in salaries and equity stakes in the firms.

The 50-year-old son of the late Sen. Edward M. Kennedy, who stepped down from Congress in 2011 amid his own decades-long battles with addiction and mental illness, is a high-profile mental health advocate who sat on President Donald Trump's opioid commission.